Forecast cancer: the importance of biomimetic 3D in vitro models in cancer drug testing/discovery and therapy

Nowadays, the pharmaceutical industry faces a significant challenge related to the high attrition rates of drugs, which is particularly astonishing in oncology [1]. Indeed, several studies have reported that about 95% of anti-cancer drugs tested in phase I fail to reach the market. The reasons for t...

ver descrição completa

Detalhes bibliográficos
Autor principal: Caballero, David (author)
Outros Autores: Kundu, B. (author), Abreu, Catarina M. (author), Amorim, S. (author), Fernandes, D. C. (author), Pires, R. A. (author), Oliveira, Joaquim M. (author), Correlo, V. M. (author), Reis, R. L. (author), Kundu, Subhas C (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
3D in vitro models
Cancer
drug screening
Drug testing
three dimensions
Texto completo:http://hdl.handle.net/1822/76682
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/76682

Texto Completo

http://hdl.handle.net/1822/76682

Registros relacionados